A Pooled-Data Analysis of Three Randomized,Double-Masked,Six-Month Clinical Studies Comparing the Intraocular Pressure Reducing Effect of Latanoprost and Timolol

Abstract

Purpose

To compare the intraocular pressure (IOP) reduction by latanoprost and timolol, and to study factors of prognostic value for assessing this reduction.

Methods

We analyzed 829 patients included in three phase III studies comparing six months' treatment with 0.005% latanoprost once daily and 0.5% timolol twice daily in patients with open-angle glaucoma or ocular hypertension. Analysis of covariance controlled for differences in baseline IOP and sex was used to assess the IOP reduction.

Results

Latanoprost reduced diurnal IOP (average of morning, noon and afternoon assessments) by 7.7 mmHg (31%) and timolol by 6.5 mmHg (26%) after six months of treatment. Thus the diurnal IOP was reduced 1.2 mmHg (18%) more with latanoprost than with timolol (p<0.001). Latanoprost-treated patients showed a further decrease in morning IOP of 0.7 mmHg (9%, p<0.001) from the initial morning IOP reduction obtained at two weeks. No such further decrease in IOP was seen with timolol. Higher baseline diurnal IOP resulted in a larger diurnal reduction during treatment with both drugs (p<0.001). Diurnal IOP in women was reduced 0.7 mmHg (11%) less than males with both drugs (p<0.001).

Conclusions

Latanoprost was more effective than timolol in reducing mean diurnal IOP. The effect after two weeks was maintained for timolol while with latanoprost there was a further, significant IOP reduction from two weeks to six months. Baseline IOP was the only factor of clinical importance found to be of prognostic value for assessing the IOP reduction.

Keywords

Open-angle glaucoma Ocular hypertension Intraocular pressure Latanoprost Prostaglandin Timolol

Get full access to this article

View all access options for this article.

References

Stjernschantz

, Resul

. Phenyl substituted prostaglandin analogs for glaucoma treatment. Drugs Future 1992; 8: 691–704.

Resul

, Stjernschantz

, No

Phenyl-substituted prostaglandins: potent and selective antiglaucoma agents.

J Med Chem 1993; 36: 243–8.

Alm

, Stjernschantz

, the Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Ophthalmology 1995; 102: 1743–52.

Watson

, Stjernschantz

, the Latanoprost Study Group. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology 1996; 103: 126–37.

Camras

C.B.

, the United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. A six-month, masked, multicenter trial in the United States. Ophthalmology 1996; 103: 138–47.

Mishima

H.K.

, Masuda

, Kitazawa

, Azuma

, Araie

. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study. Arch Ophthalmol 1996; 114: 929–32.

Alm

, Villumsen

. PhXA34 a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers. Arch Ophthalmol 1991; 109: 1564–8.

Ziai

, Dolan

J.W.

, Kacere

R.D.

, Brubaker

R.F.

. The effects on aqueous dynamics of PhXA41 a new prostaglandin F_2α analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol 1993; 111: 1351–8.

Toris

C.B.

, Camras

C.B.

, Yablonski

M.E.

. Effects of PhXA41, a new prostaglandin F_2α analog, on aqueous humor dynamics in human eyes. Ophthalmology 1993; 100: 1297–304.

10.

Crawford

, Kaufman

P.L.

. Pilocarpine antagonizes prosta- glandin F_2α induced ocular hypotension in monkeys. Evidence for enhancement of uveoscleral outflow by prostaglandin F_2α. Arch Ophthalmol 1987; 105: 1112–6.

11.

Gabelt

B.T.

, Kaufman

P.L.

. Prostaglandin F_2α increases uveoscleral outflow in the cynomolgus monkey. Exp Eye Res 1989; 49: 389–402.

12.

Nilsson

S.F.E.

, Samuelsson

, Bill

, Stjernschantz

. Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F_2α 1-isopropylester in the cynomolgus monkey. Exp Eye Res 1989; 48: 707–16.

13.

Ray

W.A.

, O'Day

D.M.

, Head

, Robinsson

. Statistical analysis for experimental models of ocular disease: continuous response measures. Curr Eye Res 1985; 5: 585–97.

14.

Analysis of covariance. In: Snedecor

G.W.

, Cochran

W.G.

, ed. Statistical methods 7th edition. The Iowa State University Press, 1980; 365–88.

15.

Regression and correlation. In: Colton

, ed. Statistics in medicine. Boston: Little Brown and Company, 1974; 189–217.

16.

Blomqvist

. On the bias caused by regression toward the mean in studying the relation between change and initial value. J Clin Periodontol 1986; 13: 34–7.

17.

Boger

W.P.

III , Puliafito

C.A.

, Steinert

R.F.

, Langston

D.P.

. Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma. Ophthalmology 1978; 85: 259–67.

18.

Gandolfi

S.A.

. Restoring sensitivity to timolol after long-term drift in primary open-angle glaucoma. Invest Ophthalmol Vis Sci 1990; 31: 354–8.

19.

Lindsey

J.D.

, Kashiwagi

, Weinreb

R.N.

. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: Implications for uveoscleral outflow. Surv Ophthalmol 1997; 41(suppl): S53–9.

20.

Ocklind

. Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections. Exp Eye Res 1998; 67: 179–91.